Lallemand Health Solutions will showcase its latest science‑backed biotic innovations at Vitafoods Barcelona, taking place May 5–7, 2026, reaffirming its commitment to clinically documented, market‑ready solutions for human health.
At this year’s event, Lallemand Health Solutions will highlight new research and expanded offerings across women’s health, cognition, immune health, and healthy aging, supporting brand partners looking to differentiate through robust science, regulatory readiness, and meaningful consumer relevance.
Probiotics for Women’s Health: Targeted Solutions Across Life Stages
Women’s health remains a high growth, innovation‑driven category, with increasing demand for evidence-based, life‑stage‑specific solutions. Lallemand Health Solutions will present a strengthened women’s health portfolio built on clinically documented probiotic strains addressing pregnancy, intimate health, digestive comfort during menstruation, and beyond.
- Prenatis™, evaluated in a large clinical trial involving 180 pregnant women, was shown to help reduce diagnosed maternal infections and to support the early establishment of a healthy infant gut microbiome, including in C‑section‑delivered newborns.
- Lacidofil® has demonstrated benefits in supporting microbial balance around C‑section delivery, particularly when taken proactively, helping mitigate antibiotic‑associated disruptions.
- For intimate health, L. plantarum Rosella, one of the most extensively studied strains in this area, supported by six clinical studies involving over 800 women, has shown its ability to support vaginal microbiota balance for recurrent vulvovaginal candidiasis (rVVC) following oral administration
- Beyond intimate health, B. bifidum Rosell®‑71 has demonstrated benefits for digestive comfort during menstruation, notably by reducing bloating across menstrual cycles.
Together, this body of clinical evidence illustrates the central role of microbiome‑targeted probiotics in supporting women’s health across key life stages and responding to unmet needs in a fast‑evolving category.
Mental Health: New Clinical Data on Cognitive Capacities
Lallemand Health Solutions will also unveil a new cognitive health offer supported by a recent clinical study conducted in action video gamers taking Cerebiome®. Preliminary results demonstrated measurable improvements in cognitive abilities, including attention-related measurements:
- Decrease in reaction time
- Improvement in processing speed
These findings open new perspectives for cognitive capacities, expanding the company’s science‑driven mental health portfolio.
Healthy Aging: Introducing Cerenity™
Healthy aging represents another major strategic focus at Vitafoods 2026. Lallemand Health Solutions will highlight Cerenity™, a flagship probiotic solution designed to support mobility, strength, and quality of life through modulation of the gut–muscle axis.
“Cerenity™ reflects our commitment to supporting healthy aging from within, through clinically documented microbiome solutions,” says Camille Binachon, Marketing Group Manager, Healthy Aging.
In a recent clinical study, Cerenity™ demonstrated beneficial effects on physical performance and quality of life in aging populations. In addition, the healthy aging portfolio continues to expand with solutions targeting cardiovascular and cognitive health, providing comprehensive support for aging well.
Award‑Winning Postbiotic Immuse® for Immune Health
Immune health will also take center stage, with Immuse®, the most documented postbiotics for immune support. Last year, Lallemand Health Solutions announced a strategic partnership with Kirin Holdings Company, Limited to expand global visibility of this clinically supported solution.
“Immuse® addresses growing demand for reliable, science‑backed immune solutions applicable to daily health, sport, and skin health,” says Romane Maillet, Marketing Group Manager, Postbiotics.
Visit Lallemand Health Solutions at Booth #3G146
Industry partners are invited to meet the Lallemand Health Solutions team at booth #3G146 to explore these innovations in detail, discuss formulation and market opportunities, and experience FizzBiotics™by Lallemand, a playful, sparkling sensory experience designed to elevate consumer experience.
About Lallemand Health Solutions
With over 90 years of expertise, Lallemand Health Solutions is a global leader in the probiotic industry, specializing in the development, production, and marketing of bacteria and yeast based biotic solutions for human health, supported by robust clinical research and regulatory expertise.
